| Title : The unique alpha4(+)\/(-)alpha4 agonist binding site in (alpha4)3(beta2)2 subtype nicotinic acetylcholine receptors permits differential agonist desensitization pharmacology versus the (alpha4)2(beta2)3 subtype - Eaton_2014_J.Pharmacol.Exp.Ther_348_46 |
| Author(s) : Eaton JB , Lucero LM , Stratton H , Chang Y , Cooper JF , Lindstrom JM , Lukas RJ , Whiteaker P |
| Ref : Journal of Pharmacology & Experimental Therapeutics , 348 :46 , 2014 |
| Abstract : Eaton_2014_J.Pharmacol.Exp.Ther_348_46 |
| ESTHER : Eaton_2014_J.Pharmacol.Exp.Ther_348_46 |
| PubMedSearch : Eaton_2014_J.Pharmacol.Exp.Ther_348_46 |
| PubMedID: 24190916 |
Eaton JB, Lucero LM, Stratton H, Chang Y, Cooper JF, Lindstrom JM, Lukas RJ, Whiteaker P (2014)
The unique alpha4(+)\/(-)alpha4 agonist binding site in (alpha4)3(beta2)2 subtype nicotinic acetylcholine receptors permits differential agonist desensitization pharmacology versus the (alpha4)2(beta2)3 subtype
Journal of Pharmacology & Experimental Therapeutics
348 :46
Eaton JB, Lucero LM, Stratton H, Chang Y, Cooper JF, Lindstrom JM, Lukas RJ, Whiteaker P (2014)
Journal of Pharmacology & Experimental Therapeutics
348 :46